Med-IQ Logo
Get CME/CE
Recognizing Gaucher’s Disease in the Hematology Clinic
Presentation Points Presentation Points

Recognizing Gaucher’s Disease in the Hematology Clinic


Time to Complete:
30 minutes
Released:
3/1/17
Expires:
2/28/18

Maximum Credits:

0.5 AMA PRA Category 1 Credit(s)
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Presentation Points Presentation Points
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.
Time to Complete:
30 minutes

Released:
3/1/17

Expires:
2/28/18

Maximum Credits:
0.5 AMA PRA Category 1 Credit(s)
Share on:
Presentation Points Presentation Points
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Share on:


Time to Complete:
30 minutes
Released:
3/1/17
Expires:
2/28/18


Maximum Credits:
0.5 AMA PRA Category 1 Credit(s)


Overview: This transcript-based, CME-certified Presentation Points publication summarizes a satellite symposium presented by Pramod K. Mistry, MD, PhD, FRCP, and Neal J. Weinreb, MD, FACP, nationally renowned experts in Gaucher’s disease (GD) type 1. Faculty present strategies for recognizing symptoms early in the disease course and discuss the implications of misdiagnosis. Additionally, faculty review the benefits and limitations of available medications and emerging treatments for this disease.

Faculty

Pramod K. Mistry, MD, PhD, FRCP

Professor of Medicine, Pediatrics, and Cellular & Molecular Physiology

Director, Metabolic Liver and Lysosomal Disease Program

Yale University School of Medicine

Department of Internal Medicine (Digestive Diseases)

Yale New Haven Hospital

New Haven, CT

Neal J. Weinreb, MD, FACP

Voluntary Associate Professor of Clinical Genetics and Medicine (Hematology)

Miller School of Medicine, University of Miami

Miami, FL

Director, University Research Foundation for Lysosomal Storage Diseases, Inc.

Boca Raton, FL


Disclosure Policy

Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

Pramod K. Mistry, MD, PhD, FRCP
Consulting fees/advisory boards: Sanofi Genzyme, Pfizer, Inc., Shire
Fees received for promotional/non-CME activities: Sanofi Genzyme
Contracted research: Sanofi Genzyme

Neal J. Weinreb, MD, FACP
Consulting fees/advisory boards: Alexion, Sanofi Genzyme, Pfizer, Inc., Shire
Fees received for promotional/non-CME activities: Sanofi Genzyme, Pfizer, Inc.
Contracted research: Sanofi Genzyme

The peer reviewers and activity planners have no financial relationships to disclose.


This activity has been approved for AMA PRA Category 1 Credit™.


This activity is supported by an educational grant from Sanofi Genzyme.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.
Play Video
The trifecta of healthcare improvement: value-based care, quality improvement, and technology.

See how Med-IQ is helping to enhance patient outcomes in these short videos.

Scott Weber, CEO Med-IQ

From Volume to Value-Based Care: The Role of the CME Enterprise

Scott Weber, CEO,
Med-IQ

Allison Gardner, PhD, VP Educational Strategy and Content, Med-IQ

The Value of Quality Improvement and Education to Advance Healthcare

Allison Gardner, PhD,
VP Educational Strategy and Content,
Med-IQ

Dr. Glenn Treisman,
Department of Psychiatry, Johns Hopkins Medical Institute

The Pros and Cons of Technology on the Practice of Medicine

Dr. Glenn Treisman,
Department of Psychiatry,
Johns Hopkins Medical Institute


Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.